Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, open-label, single-arm, optimal dose, long-term follow-up
study of monotherapy administration of rotigotine transdermal patch in adolescents with
Restless Legs Syndrome (RLS). This study will assess the long-term safety and tolerability of
Rotigotine treatment in adolescents with RLS.